000			02098 a2200577 4500
005			20250516232228.0
264		0	_c20141117
008			201411s 0 0 eng d
022			_a1521-0103
024	7		_a10.1124/jpet.114.215418 _2doi
040			_aNLM _beng _cNLM
100	1		_aChao, Ting-Ting
245	0	0	_aTD-19, an erlotinib derivative, induces epidermal growth factor receptor wild-type nonsmall-cell lung cancer apoptosis through CIP2A-mediated pathway. _h[electronic resource]
260			_bThe Journal of pharmacology and experimental therapeutics _cNov 2014
300			_a352-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aAutoantigens _xmetabolism
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xdrug therapy
650	0	4	_aCaspase 3 _xmetabolism
650	0	4	_aCaspase 9 _xmetabolism
650	0	4	_aCell Line, Tumor
650	0	4	_aDown-Regulation _xdrug effects
650	0	4	_aErbB Receptors _xmetabolism
650	0	4	_aErlotinib Hydrochloride
650	0	4	_aHumans
650	0	4	_aIntracellular Signaling Peptides and Proteins
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMembrane Proteins _xmetabolism
650	0	4	_aMice
650	0	4	_aMice, Nude
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_aPoly(ADP-ribose) Polymerases _xmetabolism
650	0	4	_aProtein Phosphatase 2 _xmetabolism
650	0	4	_aProto-Oncogene Proteins c-akt _xmetabolism
650	0	4	_aQuinazolines _xpharmacology
700	1		_aWang, Cheng-Yi
700	1		_aLai, Chih-Cheng
700	1		_aChen, Yen-Lin
700	1		_aTsai, Yi-Ting
700	1		_aChen, Pao-Tzu
700	1		_aLin, Hen-I
700	1		_aHuang, Yuh-Chin T
700	1		_aShiau, Chung-Wai
700	1		_aYu, Chong-Jen
700	1		_aChen, Kuen-Feng
773	0		_tThe Journal of pharmacology and experimental therapeutics _gvol. 351 _gno. 2 _gp. 352-8
856	4	0	_uhttps://doi.org/10.1124/jpet.114.215418 _zAvailable from publisher's website
999			_c24158353 _d24158353